Invesaro

Stocks HYPR Financial statements

Financial statements

Hyperfine, Inc. financial statements

Income statement, balance sheet and cash flow statement for the last 6 fiscal years, taken from the XBRL data Hyperfine, Inc. files with the SEC in its annual reports.

In USD millions, except per-share amounts. Outflows in the cash flow statement are negative.

Income statement

FY2021FY2021FY2022FY2023FY2024FY2025
Revenue0.291.56.811112.913.6
Cost of revenue0.772.665.916.2876.81
Gross profit-0.48-1.170.914.765.896.75
Research and development14.625.828.222.522.517.5
Selling and marketing2.510.414.210.19.1210.1
General and administrative5.9227.532.420.317.516.3
Operating expenses2363.774.852.949.143.8
Operating income-23.5-64.9-73.9-48.1-43.2-37.1
Interest income0.070.020.763.842.491.02
Other non-operating income-0.01-0-0.050.040.01-0.34
Pre-tax income-23.4-64.9-73.2-44.2-40.7-35.6
Income tax00000
Net income-23.4-64.9-44.2-44.2-40.7-35.6
EBITDA-23.2-64.1-72.9-47.1-42.2-36
EPS, basic-15.38-17.57-1.04-0.62-0.56-0.43
EPS, diluted-15.38-17.57-1.04-0.62-0.56-0.43
Shares, basic (weighted)1.523.6970.471.372.481.8
Shares, diluted (weighted)1.523.6970.471.372.481.8

Balance sheet

FY2021FY2021FY2022FY2023FY2024FY2025
Cash and equivalents62.718811775.237.635.1
Receivables0.170.552.13.195.965.25
Inventory1.724.314.626.585.837.09
Other current assets0.691.363.192.391.91.26
Total current assets68.319712988.953.750.9
Property, plant and equipment1.93.753.2533.122.55
Lease right-of-use assets0.240.340.32
Other non-current assets0.041.242.142.292.071.8
Total assets71.520213494.258.955.3
Accounts payable0.952.250.681.211.614.05
Accrued liabilities0.441.880.680.760.76
Deferred revenue0.160.731.381.451.461.54
Total current liabilities4.1215.78.88.778.7311.7
Long-term debt0.180
Lease liabilities0.060.080.07
Other non-current liabilities0.060.080.07
Total liabilities4.2916.210.39.89.8614.3
Total debt0
Paid-in capital10.4323333338343371
Retained earnings-71.5-136-209-254-294-330
Shareholders' equity-61.118612484.44941
Total equity-61.118612484.44941
Total liabilities and equity71.520213494.258.955.3

Cash flow statement

FY2021FY2021FY2022FY2023FY2024FY2025
Net income-23.4-64.9-73.2-44.2-40.7-35.6
Depreciation and amortization0.290.731.021.051.011.09
Stock-based compensation1.126.910.74.744.362.8
Change in receivables-0.17-0.38-1.55-1.09-2.770.7
Change in inventory-1.93-2.67-0.31-2.210.56-1.48
Change in payables-0.381.44-1.570.530.382.43
Cash from operations-21.5-47.2-72.3-41.8-38.8-27.9
Capital expenditures-1.57-2.71-0.59-0.8-0.38-1.19
Cash from investing-1.57-2.71-0.59-0.8-0.38-1.19
Stock issued0.121.50.010.170.170.16
Cash from financing60.91770.010.171.0227.5
Net change in cash37.8127-72.9-42.4-38.1-1.63
Free cash flow-23.1-49.9-72.9-42.6-39.2-29.1
Income taxes paid0

Key metrics

Worked out from the statements above. Latest values use the trailing twelve months to June 30, 2026; growth uses fiscal years. Valuation uses the share price of $0.81 on September 25, 2026.

Profitability

MetricValueHow it is calculated
Gross margin51.4%Gross profit / revenue.
Operating margin-203.3%Operating income / revenue.
EBITDA margin-196.5%EBITDA (operating income + depreciation and amortization) / revenue.
Pre-tax margin-210.8%Pre-tax income / revenue.
Net margin-210.8%Net income / revenue.
FCF margin-166.5%Free cash flow (cash from operations - capital expenditures) / revenue.
Operating cash flow margin-163.7%Cash from operations / revenue.
Return on equity (ROE)-94.8%Net income / average shareholders' equity (opening and closing). Not shown when equity is negative.
Return on assets (ROA)-55.3%Net income / average total assets.
Return on invested capital (ROIC)-406.4%Approximation: operating income x (1 - tax rate) / average (total debt + equity - cash). Tax rate is the effective rate when between 0% and 50%, else 21%.
R&D / revenue94.2%Research and development expense / revenue.
Stock-based pay / revenue17.3%Stock-based compensation (from the cash flow statement) / revenue.
Capex / revenue2.8%Capital expenditures / revenue.
D&A / revenue6.7%Depreciation and amortization / revenue.

Growth

MetricValueHow it is calculated
Revenue growth, 1y5.2%Revenue vs the same period a year earlier. Only from a positive base.
Revenue CAGR, 3y25.8%Compound annual growth of revenue over 3 fiscal years: (end / start)^(1/3) - 1. Only when both values are positive.
Revenue CAGR, 5y115.2%Compound annual growth of revenue over 5 fiscal years: (end / start)^(1/5) - 1. Only when both values are positive.
Gross profit growth, 1y14.6%Gross profit vs the same period a year earlier. Only from a positive base.
Gross profit CAGR, 3y95.3%Compound annual growth of gross profit over 3 fiscal years: (end / start)^(1/3) - 1. Only when both values are positive.
Book value growth, 1y-16.4%Book value vs the same period a year earlier. Only from a positive base.
Book value CAGR, 3y-30.8%Compound annual growth of book value over 3 fiscal years: (end / start)^(1/3) - 1. Only when both values are positive.
Total assets growth, 1y-6.2%Total assets vs the same period a year earlier. Only from a positive base.
Total assets CAGR, 3y-25.6%Compound annual growth of total assets over 3 fiscal years: (end / start)^(1/3) - 1. Only when both values are positive.
Total assets CAGR, 5y-5.0%Compound annual growth of total assets over 5 fiscal years: (end / start)^(1/5) - 1. Only when both values are positive.
Share count change, 1y13.0%Change in diluted weighted shares vs a year earlier. Negative means buybacks shrank the share count; positive means dilution.
Share count change per year, 3y5.1%Change in diluted weighted shares, per year over 3 years. Negative means buybacks shrank the share count; positive means dilution.
Share count change per year, 5y121.8%Change in diluted weighted shares, per year over 5 years. Negative means buybacks shrank the share count; positive means dilution.

Balance sheet health

MetricValueHow it is calculated
Current ratio6.15xCurrent assets / current liabilities.
Quick ratio4.95x(Cash + short-term investments + receivables) / current liabilities.
Cash ratio4.51x(Cash + short-term investments) / current liabilities.
Debt / equity0.36xTotal debt / shareholders' equity. Not shown when equity is negative.
Debt / assets21.0%Total debt / total assets.
Liabilities / assets41.7%Total liabilities / total assets.
Net debt-$30.2MTotal debt - cash - short-term investments. Negative means more cash than debt.
Working capital$49.6MCurrent assets - current liabilities.
Tangible book value$36.8MShareholders' equity - goodwill - intangible assets.

Efficiency

MetricValueHow it is calculated
Asset turnover0.26xRevenue / average total assets.
Fixed asset turnover7.31xRevenue / average property, plant and equipment.
Inventory turnover1.18xCost of revenue / average inventory.
Days inventory308 days365 x average inventory / cost of revenue.
Receivables turnover3.92xRevenue / average receivables.
Days sales outstanding93 days365 x average receivables / revenue.
Days payables110 days365 x average accounts payable / cost of revenue.
Cash conversion cycle291 daysDays inventory + days sales outstanding - days payables.

Per share

MetricValueHow it is calculated
EPS, diluted-$0.35Net income per diluted share, as reported (split-adjusted). Over the last twelve months: the four quarters summed, or net income / latest diluted shares when a quarter has no reported EPS.
Revenue per share$0.17Revenue / diluted weighted shares.
FCF per share-$0.28Free cash flow / diluted weighted shares.
Operating cash flow per share-$0.27Cash from operations / diluted weighted shares.
Book value per share$0.37Shareholders' equity / shares outstanding (diluted weighted shares when not reported).
Tangible book per share$0.37Tangible book value / shares outstanding.
Cash per share$0.44(Cash + short-term investments) / shares outstanding.

Valuation

MetricValueHow it is calculated
Market cap$86.2MShare price x shares outstanding.
Enterprise value$56.0MMarket cap + total debt - cash - short-term investments.
P/S5.22xMarket cap / revenue.
P/B2.35xMarket cap / shareholders' equity. Only when equity is positive.
Price / tangible book2.35xMarket cap / tangible book value, when positive.
EV/Sales3.39xEnterprise value / revenue.
FCF yield-31.9%Free cash flow / market cap.
Earnings yield-40.4%Net income / market cap (the inverse of P/E).
What was Hyperfine, Inc.'s revenue in fiscal 2025?

Hyperfine, Inc. reported revenue of $13.6M for fiscal 2025, 5.2% higher than the year before.

Was Hyperfine, Inc. profitable in fiscal 2025?

No. It reported a net loss of $35.6M.

How much free cash flow did Hyperfine, Inc. generate in fiscal 2025?

Cash from operations of $27.9M minus capital expenditures of $1.2M left free cash flow of -$29.1M.

Source: SEC EDGAR XBRL company facts. Where a company tags only year-to-date figures, quarters are worked out as differences. Where a line is not tagged it is left empty, never estimated.

Open interactive statements, quarterly figures and charts

Back to Hyperfine, Inc.